XML 33 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenues $ 27,614 $ 2,500
Operating expenses:    
Research and development 12,066 12,356
Selling, general and administrative 51,578 15,096
Total operating expenses 65,298 27,452
Loss from operations before other income (expense) (37,684) (24,952)
Other income (expense):    
Interest income 3,117 2,293
Interest expense (983) (684)
Other income, net 605 6
Unrealized loss on equity investments (585) (65)
Change in fair value of equity warrants issued by licensee (201) (17)
Total other income, net 1,953 1,533
Net (loss) income (35,731) (23,419)
Other comprehensive loss:    
Unrealized (loss) gain on marketable securities and cash equivalents (61) 4
Comprehensive loss $ (35,792) $ (23,415)
Earnings Per Share [Abstract]    
Net loss per share, basic (usd per share) $ (1.01) $ (0.88)
Net loss per share, diluted (usd per share) $ (1.01) $ (0.88)
Weighted Average Number of Shares Outstanding, Diluted [Abstract]    
Weighted-average shares outstanding, basic (shares) 35,300,655 26,742,023
Weighted-average shares outstanding, diluted (shares) 35,300,655 26,742,023
Product    
Revenues:    
Total revenues $ 24,720 $ 0
Operating expenses:    
Cost of sales 1,654 0
License fees and Collaboration    
Revenues:    
Total revenues $ 2,894 $ 2,500